Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company For-Robin Inc.
DescriptionMAb that binds to the Thomsen-Friedenreich (TF) antigen
Molecular Target Thomsen-Friedenreich antigen (TF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today